China's medical products administrator approved APT Medical (SHA:688617) subsidiary Shenzhen Huitai Medical Device's registration for its disposable magnetoelectric positioning pressure monitoring pulse electric field ablation catheter, according to a Thursday filing with the Shanghai bourse.
The device is intended for the treatment of drug-refractory, recurrent, and symptomatic paroxysmal atrial fibrillation or abnormal electric impulses in the heart.
The device is used with the cardiac pulse electric field ablation device produced by Shanghai Hongtong Industrial.
Shares fell 1% during Thursday's trading.